Latest filing published 08 Jan 2025 for Poseida Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Marcea Bland Lloyd in Poseida Therapeutics, Inc., where the filings describe the role as board member. Over a trading history stretching from 16 June 2022 to 8 January 2025, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 8 January 2025 came the latest disclosure, a transaction in Poseida Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations